Ziauddin Hospital Launches Robotic Surgery Programme in Karachi
Dr Ziauddin Hospital has inaugurated a robotic surgery programme in Karachi, adding robotic-assisted technology to its surgical services.
Hospital chairman Dr Asim Hussain formally opened the programme at the Department of Surgery on Saturday, October 3, according to APP’s coverage of the ceremony. APP report
Hospital Emphasises Surgeon Training
Speaking at the launch, Dr Asim Hussain said the hospital had prioritised surgeon training and the supporting infrastructure before introducing the programme.
Chief Executive Dr Ammad Hussain described robotic assistance as a further development in surgical practice following conventional and laparoscopic techniques. Hospital officials said the technology could give surgeons greater precision and control. The News
Programme Covers Several Surgical Specialties
Dr Haris Rashid, the hospital’s Chair of Surgery, outlined potential applications across:
- General surgery
- Cancer surgery
- Colorectal surgery
- Urology
- Gynaecology
- Cardiac surgery
These were the areas identified at the launch; the announcement did not provide a procedure-by-procedure availability schedule. The News
Two Procedures Reported at the Ceremony
APP reported that the hospital’s chief executive said two successful surgeries had already been performed.
That statement represents the hospital’s account of its initial experience. The report does not provide detailed patient outcomes, follow-up periods or comparative clinical data. APP report
How Robotic-Assisted Surgery Works
Robotic-assisted surgery allows a surgeon to control surgical instruments using computer-assisted technology, often through small incisions.
The surgeon directs the procedure. The equipment assists with instrument movement rather than independently deciding how to operate.
The US Food and Drug Administration explains that these systems can be safe and effective for certain procedures when used appropriately by properly trained teams. Suitability depends on the specific operation and clinical circumstances. FDA explanation
Precision Claims Need Procedure-Specific Evidence
Greater instrument control is a feature of robotic-assisted technology, but it should not be treated as proof of better results in every operation.
The FDA advises patients to discuss the benefits, risks and alternatives with their healthcare provider, including the surgical team’s experience with the proposed procedure. FDA guidance
For this programme, independent assessment would require more information about the procedures performed and their outcomes. The inauguration reports mainly describe the hospital’s capabilities and expectations.
Costs and Access Remain Important Questions
The reports reviewed do not provide a patient price list, insurance coverage details or a full booking schedule.
Those details will help establish how widely patients can access the new service. They will also allow prospective patients to compare the total cost and available treatment options.
What the Launch Means for Karachi
The programme adds another surgical technology option within Karachi’s private healthcare sector.
Its longer-term significance will depend on how the hospital combines equipment, trained teams and patient selection—and whether it publishes measurable results as the programme develops.
For now, the confirmed development is the inauguration of Ziauddin Hospital’s robotic surgery programme, alongside hospital-reported initial procedures and plans for use across multiple specialties.